NCT07894705Not yet recruiting
Blood Pressure Goal in Preterm Preeclampsia
Blood Pressure Goal in Preterm Preeclampsia (BLiPP)
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
The purpose of this study is to compare latency (prolongation of pregnancy from diagnosis till delivery) in patients with hypertensive disorders of pregnancy (HDP) with severe features \< 34 weeks gestational age (GA), undergoing expectant management between tight and permissive blood pressure (BP) groups.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 68 (estimated)
- First submitted
- 6 Oct 2026
- Start date
- Nov 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Ohio State University
- Diseases
- High blood pressure
- NCT number
- NCT07894705
What you commit to
- Study type: Observational
- Planned participants: 68
- From Nov 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Poorly controlled preexisting chronic hypertension on ≥2 oral antihypertensive medications
Lab values
- Preexisting CKD with serum creatinine \> 1.0
Other
- HDP with severe features \> 32 weeks gestation at the time of admission
- Contraindications to expectant management of preeclampsia with severe features per ACOG (attached)
- Severe FGR (EFW \< 3rd percentile) or FGR with umbilical artery doppler abnormalities (absent or reversed end diastolic flow) at the time of enrollment
- Multiple gestation
- Major fetal anomaly (attached)
- PPROM/active preterm labor
Who the study is looking for
- Pregnant individuals
- Age ≥ 18 years old
- HDP with severe features
- Planned inpatient admission for expectant management until delivery
- GA 24 - ≤ 32 weeks GA
- Singleton, non-anomalous fetus
- Anticipated delivery at the study institution
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ohio State University Wexner Medical Center Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.